Novo Nordisk downgraded by BMO as Eli Lilly gains ground in weight-loss drug race
Investing.com -- BMO Capital Markets downgraded Novo Nordisk (NYSE: NVO ) to “Market Perform” from “Outperform” and cut its price target to $64, saying the Danish drugmaker’s e...
CFTC reports and Fed’s Daly speech highlight Friday’s economic events
As traders approach another pivotal day for financial markets on Friday, April 18, 2025, a series of crucial economic data releases and a key Federal Reserve speech are expected to sway marke...
US Treasury in talks with federal agencies to ease bank oversight, Bloomberg News says
(Reuters) - U.S. Treasury Secretary Scott Bessent is hosting private meetings with federal and other bank agencies as a part of his expanded effort to streamline oversight and coordinate plan...
